ImmunoGen Message Board - Msg: 30387200

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	1/3/2016 3:26:27 PM
	Read Replies (1) of 5665

I cannot say that 2015 was a great year for IMGN shareholders, yet if you look at the price on December 31 in 2014 and 2015 you'll see it more than doubled, so you really can't say it was a bad year. This year has the potential to be a great year as more data is provided from a number of trials, and some advancements are made in both IMGN owned and partners drugs in trials. By a great year, I'm speaking of at least a double, and really the possibility of generating new all time highs, that's over $45. I cannot say what SGEN will do, but to me IMGN ought to be trading at roughly SGEN's market cap, rather than a small fraction of it. Hopefully this is the year this occurs. Happy New Year's all, Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next